Capacitive immunosensor based on grafted Anodic Aluminum Oxide for the detection of matrix metalloproteinase 9 found in chronic wounds.

Anodic aluminum oxide Antibody immobilization Capacitive sensor Chronic wounds Matrix metalloproteinases

Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
01 10 2023
Historique:
received: 23 03 2023
revised: 07 08 2023
accepted: 09 08 2023
medline: 23 8 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

Chronic wounds impose a significant burden on healthcare resources, society and more specifically on patients. Preliminary research showed that as of today, there is not a system that can do a precise monitoring of these wounds so that healthcare systems can manage them with efficiency. The overall aim of our project is to produce a capacitive sensor able to detect a specific molecule in chronic wounds, thus giving information concerning its inflammation state. In this article, we present a system that uses nanoporous Anodic Aluminum Oxide (AAO) grafted with a commercially available anti-MMP9 antibody able to interact with Matrix Metalloproteinase 9, an enzyme that works as an indicator of inflammation. In order to produce a proof-of-concept we chose to compare two methods of functionalization followed by a thorough analysis with biological, electrical and optical testing. This study produced reproducible results for each functionalization method, chemisorption being the best choice for the immobilization of conventional antibodies on AAO-based sensors for a detection of MMP9 in pure and complex conditions. This proof-of-concept and its analysis allowed a better understanding of the needs of the overall project and will be helpful to produce a prototype of smart dressing in the near future.

Identifiants

pubmed: 37572841
pii: S0003-2697(23)00247-6
doi: 10.1016/j.ab.2023.115282
pii:
doi:

Substances chimiques

Aluminum Oxide LMI26O6933
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115282

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pauline Choma (P)

Institut d'Electronique et des Systèmes, CNRS UMR5214, Université Montpellier, 860 rue Saint Priest, 34090, Montpellier, France.

Ingrid Bazin (I)

LGEI, IMT Mines Ales, Université de Montpellier, 6 avenue de Clavières, 30319, Ales Cedex, France.

Martine Cerutti (M)

Unité Baculovirus et Thérapie, Station Recherche, CNRS UPS3044, 410 chemin des Boissières, 30380, Saint Christol Lès Alès, France.

Arnaud Vena (A)

Institut d'Electronique et des Systèmes, CNRS UMR5214, Université Montpellier, 860 rue Saint Priest, 34090, Montpellier, France.

Brice Sorli (B)

Institut d'Electronique et des Systèmes, CNRS UMR5214, Université Montpellier, 860 rue Saint Priest, 34090, Montpellier, France. Electronic address: brice.sorli@umontpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH